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Abstract
OBJECTIVES: Cardiac venous arterialization has been proposed as an alternative approach for myocardial revascularization in ischaemic
heart disease. It is based on using the cardiac venous system to transport arterial blood from a systemic artery to infarcted myocardial
areas. Our goal was to evaluate its beneﬁt in reducing acute myocardial infarct size and its effects on cardiac performance.
METHODS: In a group of pigs, the left internal mammary artery was anastomosed to the left anterior descending vein; this vein was
ligated proximally. The left anterior descending coronary artery was also occluded. Over 5 days, several diagnostic procedures were
used to characterize and measure the extent of myocardial infarct, namely ECG, echocardiography, cardiac biomarkers and histopath-
ology. Data were compared with those from a control group of pigs, which were submitted to ligation of only the left anterior descend-
ing coronary artery.
RESULTS: In the experimental group, echocardiography revealed that the ejection fraction and thickness of the ventricular walls
remained unchanged 4 days after surgery, in contrast to the major alterations in the control group. In fact, the ejection fraction in the
control group decreased by 21% (P < 0.001), with a reduction of 31% (P < 0.004) in the thickness of the interventricular septum at end
systole and enlargement of the left ventricular lumen by 28% (P < 0.001). In the experimental group, the sum for ST segment shift was
50% lower (P = 0.038) and the total ventricular histological lesion size was 50% smaller (P < 0.001). Within this lesion, the area of necrotic
tissue was 70% smaller (P < 0.001). Cardiac biomarkers were not different between the two groups (P > 0.2).
CONCLUSIONS: This study reveals that selective cardiac venous arterialization can nourish the myocardium and is able to reduce
infarct size by more than 50%, while protecting cardiac performance. We believe, therefore, that further investigation should be carried
out into this technique in order for it to be considered as an option in coronary surgery.
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INTRODUCTION
Ischaemic cardiomyopathy is a major cause of death in devel-
oped countries, with myocardial infarction (MI) being its most
common and deadliest form. When the disease is due to focal
and proximal narrowing of epicardial coronary arteries, coronary
artery bypass grafting or percutaneous coronary interventions,
such as angioplasty (with or without stents), are often successful
therapeutic strategies. Unfortunately, atherosclerosis continues to
progress, and the frequency of coronary restenosis is still high.
Besides, neither of these techniques can be applied to patients
with widespread coronary lesions [1, 2]. For these patients, a po-
tential therapeutical approach would be to use their cardiac
venous vasculature to transport arterial blood to the
myocardium. Other interesting approaches, such as transmyocar-
dial laser revascularization and regenerative therapies (using
stem cells or genes), are also under investigation and have been
used in clinical trials, mainly as adjunctive therapies in coronary
artery bypass grafting. However, besides the risks involved, these
techniques require optimization, and larger scale studies need to
be performed for clear demonstration of efﬁcacy and safety
[3–5].
In the present experimental investigation, we have revisited
the usefulness of revascularization of infarcted areas through
cardiac venous arterialization. We used two groups of pigs. The
control group was submitted to ligation at only the middle point
of the left anterior descending coronary artery (LAD), in order to
induce focal MI close to the apex of the heart. These animals
were used as a control group. Using the same area at risk, the†Both authors have contributed equally to this study.
© The Author 2012. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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experimental group was submitted to both mid-LAD ligation and
cardiac venous arterialization, by grafting the left internal
mammary artery (LIMA) to the left anterior descending coronary
vein (LADV). This graft allowed the arterial blood coming from
the LIMA to ﬂow in a retrograde direction through the cardiac
venous system, thereby reaching the myocardial capillaries.
Additionally, the LADV was ligated proximally to the established
shunt to avoid backﬂow into the coronary sinus, thus improving
the blood ﬂow towards the myocardial capillaries. Pigs from
both groups were followed up for 5 days, and several parameters
were evaluated before and after the surgical procedure, namely
cardiac biochemical markers, ECGs and echocardiograms. After
the pigs were killed, hearts were collected and analysed histolo-
gically to quantify necrotic lesions and granulation tissue.
Through comparison of cardiac data between the two groups, it
was possible to determine to what extent the arterialized LADV
can rescue/prevent infarcted myocardial lesions.
With this research, and through the use of modern diagnostic
equipment, it is our goal to contribute more accurate informa-
tion regarding the efﬁcacy of cardiac venous arterialization in
reaching inaccessible ischaemic myocardial areas and its ability
to preserve cardiac performance. As an ultimate goal, we expect
this technique to reduce the mortality and morbidity of patients
with ischaemic coronary disease, at least for those patients con-
sidered inoperable by other revascularization methods, who rep-
resent 12–15% of the total number of candidates [2].
MATERIALS AND METHODS
We used 26 healthy male pigs, of Landrace mixed breed, 3
months old and weighing between 34 and 40 kg. All experiments
were conducted according to the European Union Directive no.
86/609/CEE for the use of animals in research.
For the control group, MI was induced in 13 pigs by surgical
ligation at the middle point of the LAD. Detailed information
about this model was previously published elsewhere [6]. The
described anaesthetic protocol, intraoperative and postoperative
care were performed identically in both groups (control and
experimental).
In the experimental group, 13 pigs underwent mid-LAD ligation
and cardiac venous arterialization. After partial sternotomy (the
manubrium was spared), a sternal retractor (GeoMed® LA 330-00,
Tuttlingen, Germany) was used to provide full exposure of the
LIMA and the left surface of the heart. The LIMA was carefully dis-
sected and released throughout the whole length of the sternum,
by use of an electric scalpel (Diatermo®; Top-Sharp International
Enterprise, Hong Kong, China) and by double clipping its second-
ary branches (small SLS™ clips; MoonSurge, Lisbon, Portugal). The
distal end of the LIMA was secured with a clamp and transected,
in order to tunnel it through the pericardium to reach the LADV.
The LADV was then prepared for anastomosiis with the LIMA. For
this purpose, by use of a cardiac stabilizer (Medtronic® Octopus;
International Trading, Sàrl Tolochenaz, Switzerland), a small cut
2 mm in length was performed on the LADV to permit intralum-
inal introduction of a 2.5-mm intracoronary shunt (Medtronic
Clearview®, Minneapolis, MN, USA), at a point midway between
the apex and the base of the heart (Fig. 1). An end-to-side
anastomosis from the LIMA to the LADV was accomplished, by
use of non-absorbable monoﬁlament sutures (Prolene® 8–0).
Immediately before completion of the anastomosis, the intracor-
onary shunt was removed. The LADV was ligated proximally to
the anastomosis (2 cm) and the LAD was also ligated at its mid-
point, with silk sutures (Silkam® 2–0; B Braun Medical, Oeiras,
Portugal). The temporary atraumatic clamp (Geister T03,
Tuttlingen, Germany) used at the LIMAwas then released, and ob-
servation of blood ﬂow from the LIMA to the LADV conﬁrmed
the integrity of the anastomosis.
Exactly as for the control group, an intravenous injection of
5000 IU heparin was administered prior to LAD occlusion. This
was followed by daily intravenous administration of acetylsalicyl-
ic acid until the ﬁfth day after surgery. Chest closure and place-
ment of chest tubes was performed as for the control group.
The surviving animals were killed on the ﬁfth day. For com-
parison of cardiac performance and the affected myocardial area
between the two groups, the same experimental conditions
were used for both groups, and quantiﬁcation of cardiac biomar-
kers, ECGs, echocardiography and detailed histological studies
were performed blindly by independent investigators. A brief
description of the diagnostic methods is stated here; more
details are found in another report [6].
Cardiac biomarkers included troponin I, myoglobin, total cre-
atine kinase, isoenzyme MB of creatine kinase (activity and mass
assays) and lactate dehydrogenase. Serial blood samples were
collected via a central venous catheter prior to surgery, every
2 h during the ﬁrst 10 h after surgery and then every 24 h until
the pigs were killed. Results are presented as the area under
the curve (AUC) and peak values of each biomarker.
Electrocardiograms were performed prior to surgery and then
1 h and 4 days after surgery, whereas echocardiograms were
done before surgery and 4 days later. Pigs were always under
general anaesthesia during these examinations. For ECGs, pre-
cordial leads were included in order to determine the ventricular
wall segment affected more precisely. For comparison of results,
the sum of absolute ST segment deviation (elevation or depres-
sion) was calculated for all leads that measured 60 ms after the J
Figure 1: Schematic illustration of cardiac vessels, occlusion sites and arterio-
venous anastomosis. GCV: great cardiac vein; LAD: left anterior descending
coronary artery; LADV: left anterior descending vein; LCx: left circumﬂex
artery; LIMA: left internal mammary artery.
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point relative to the TP segment. With echocardiography, the
ventricular wall contraction was visually evaluated, and measure-
ments of the left ventricular lumen and wall thicknesses allowed
calculation of the ejection fraction, for ascertainment of cardiac
performance. Full design and data collection for both ECGs
(method GUSTO-I) and echocardiography are described else-
where [6, 7].
Histological studies were performed after the pigs were killed
on the ﬁfth day. Hearts were collected and ﬁxed in 10% formalde-
hyde. For conﬁrmation of complete arterial occlusion, the LAD
was cannulated and, through injection of saline solution, visual in-
spection for leaks at the ligature site and absence of ﬁlling of
distal arterial branches was performed. Likewise, the LIMA was
cannulated for injection of saline solution to evaluate patency of
the arteriovenous grafts and ﬁlling of the distal venous tributaries.
The hearts were then sectioned in transverse slices (1 cm wide)
from the apex to the heart base. From each of these slices, the full
basal surface (including septum and both ventricles) was divided
into small blocks, which were processed, parafﬁnized and stained
with haematoxylin and eosin and Masson’s trichrome. These
stainings allowed recognition of infarcted and healthy myocardial
areas, which were measured using speciﬁc software (Image®,
National Institutes of Health) to determine with precision the per-
centage of infarcted myocardial area in each pig. To enhance the
macroscopic difference of the extent of infarcts in the two groups,
and for photographic purposes only, three hearts were selected
(two from control pigs and one of the experimental group) and
stained with 2% 2,3,5-triphenyltetrazolium chloride. The apical
surfaces of their transverse slices (where infarcts were visually
identiﬁed) were incubated in 2,3,5-triphenyltetrazolium chloride
at 37°C for 20 min. With this stain, necrotic myocardium appears
pale and viable myocardium stains dark red [8].
Statistics
Statistical analysis was performed using the PASW package, version
18.00. All data are presented as means ± SEM. For all the variables
included in this study, a Kolmogorov–Smirnov one-sample
goodness-of-ﬁt test was used to conﬁrm normality. Student’s t test
for independent samples was used when comparing means.
RESULTS
Four animals from each group (control and experimental) died
either during or shortly after surgery, owing to technical
Figure 2: M-mode echocardiography in one pig from the control group, at baseline (A) and on the fourth day (B), and in one pig from the experimental group, at
baseline (C) and on the fourth day (D). EF: ejection fraction; HR: heart rate; IVSd: thickness of interventricular septum at end diastole; IVSs: thickness of interventri-
cular septum at end systole; LVIDd: left ventricular internal diameter at end diastole; LVIDs: left ventricular internal diameter at end systole; LVPWd: left ventricular
posterior wall at end diastole; LVPWs: left ventricular posterior wall at end systole; %FS, percentage of fractional shortening.
O
R
IG
IN
A
L
A
R
TI
C
LE
M. Munz et al. / Interactive CardioVascular and Thoracic Surgery 309
problems or the MI itself; therefore, we present here the results
from nine animals in each group.
Electrocardiography
Control group. One hour after coronary occlusion, all ECGs
presented ST segment deﬂections, as well as variable changes in
heart rate and polarity of the T wave. The average sum of ST
segment shift was 7.8 ± 1.9 mm. The ST segment changes
disappeared completely by the fourth day postsurgery in six
pigs. All pigs presented positive T waves at baseline, which
shifted 1 h after coronary occlusion in three animals. Four days
later, ﬁve pigs presented a negative T wave.
The average heart rate was 85.2 ± 3.1 beats/min at baseline
and 86.8 ± 8.9 beats/min 1 h after surgery. On the fourth day, it
had increased to 115.1 ± 15.4 beats/min.
Experimental group. ST deﬂections were present in all pigs
1 h after surgery. The average sum of ST segment shift was
3.8 ± 1.1 mm. On the fourth day, these ST segment changes were
totally resolved in ﬁve animals. The T waves were positive in all
pigs at baseline. One hour after surgery and at the fourth day, all
ECGs except one displayed negative T waves. Heart rate was
unchanged from basal values to 1 h postsurgery (80.0 ± 3.3 and
79.1 ± 4.3 beats/min, respectively), but it increased until the
fourth day (122.4 ± 8.5 beats/min).
Echocardiography
Control group. The echocardiography performed 4 days after
surgery revealed a severe impairment in contractility of the
interventricular septum (example in Fig. 2A and B). The ejection
fraction decreased by 21% (P < 0.001), with a reduction of 31%
(P < 0.004) in the thickness of the interventricular septum at end
systole and evidence of enlargement (28%) of the left ventricular
lumen (P < 0.001; Table 1). The thickness of the posterior wall
did not show signiﬁcant differences (P = 0.207; Table 1).
Experimental group. After surgery, the ejection fraction was
similar to baseline (Table 1; example in Fig. 2C and D).
Regarding the measurements of the left ventricular wall and
lumen, there were also no changes, as can be seen in Table 1.
Histological studies
Control group. At postmortem examination, complete
occlusion of the LAD at its mid-point was conﬁrmed in all pigs.
Histological results were fairly similar among the different
animals. The total measured area of MI was 13.7 ± 1.0%. Within
this area, necrotic tissue occupied 5.5 ± 1.0%, while the
surrounding granulation tissue occupied 8.2 ± 0.5%. Infarcts were
transmural in both ventricles, with the main area of lesion being
located at the interventricular septum (Fig. 3A).
The total infarcted lesion in the left ventricle was more exten-
sive than the one in the right ventricle (14.8 ± 1.2 vs. 10.8 ± 1.9%;
P = 0.048). Granulation tissue was present in identical proportions
in both ventricles (7.9 ± 0.8% in the left ventricle and 9.3 ± 1.7%
in the right ventricle; P = 0.47); however, the left ventricle had a
much wider necrotic area compared with the necrotic area in
the right ventricle (6.8 ± 1.3 and 1.5 ± 0.5%, respectively; P = 0.03).
Experimental group. Postmortem examination conﬁrmed that
total occlusion of the LAD at its mid-point was achieved in all
animals, as well as a patent arteriovenous anastomosis. The
measured MI lesion in this group was 6.8 ± 1.2%. Within this
area, necrotic tissue occupied 1.6 ± 0.5%, while the surrounding
Table 1. Echocardiographic results at baseline and on the fourth day in each group
Group EF (%) IVSs (mm) LVIDs (mm) LVPWs (mm)
0 h 96 h 0 h 96 h 0 h 96 h 0 h 96 h
Control (mean ± SEM; n = 9) 59.8 ± 2.6 47.2*** ± 2.4 12.2 ± 0.7 8.4** ± 0.7 29.1 ± 1.6 37.2*** ± 1.7 12.5 ± 0.7 14.2 ± 1.1
Experimental (mean ± SEM; n = 9) 56.0 ± 3.3 53.9 ± 3.4 10.3 ± 0.7 10.8 ± 1.2 31.5 ± 2.4 34.2 ± 2.8 12.0 ± 0.8 13.5 ± 0.6
EF: ejection fraction; IVSs: thickness of interventricular septum at end systole; LVIDs: left ventricular internal diameter at end systole; LVPWs: left ventricular
posterior wall at end systole. **P < 0.01, ***P < 0.001 vs 0 h.
Figure 3: Transverse cardiac slices from one pig in the control group (A) and
one pig in the experimental group (B), stained with triphenyltetrazolium
chloride (×1.0 magniﬁcation). (A) From the total of seven cardiac slices, the
ﬁve shown here presented lesions; the infarct was transmural in both ventri-
cles and mainly located at the left part of the interventricular septum and an-
terior wall of both ventricles. (B) From a total of eight cardiac slices, only the
three shown here were affected; the area of lesion was hardly recognized, but
mainly located at the subendocardial part of the interventricular septum.
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granulation tissue occupied 5.2 ± 0.7%. Infarcts were transmural
in only three hearts. The other six hearts displayed
subendocardial or scattered areas of lesion (Fig. 3B).
The left ventricle was more affected than the right ventricle
(7.7 ± 0.9 vs. 3.9 ± 0.3%; P = 0.0026). The granulation tissue was
present in identical proportions in both ventricles (5.6 ± 0.6% in
the left ventricle and 3.9 ± 1.3% in the right ventricle; P = 0.28). In
the left ventricle, the area of necrotic tissue was only 2.1 ± 0.7%,
while the right ventricle did not present any necrotic areas.
Cardiac biochemical markers
In both groups, the concentrations of cardiac biomarkers
increased rapidly within the ﬁrst 10 h and then slowly decreased
until the ﬁfth day. Differences in the curve shape, peak values
and AUC were observed between individuals within each group.
The AUC and peak values of troponin I, myoglobin and mass
assay of creatine kinase (MMB) are shown in Table 2.
DISCUSSION
Our optimized model
Retroperfusion through the coronary sinus or arterialization of
selected cardiac veins has been performed in experimental
animal models (and even in a few human patients), mainly
during the 1970s. Despite the obsolete diagnostic methods used,
several scientists have provided good evidence that, in the acute
phase of MI, these techniques are able to perfuse the myocar-
dium, maintain metabolism, limit infarct size and maintain left
ventricular function [9–16]. After the 1970s, research on cardiac
venous arterialization was much reduced and only scarce litera-
ture can be found, probably as a result of the success of the two
newly developed techniques, namely angioplasty and surgical
bypass [8, 17–22]. The most remarkable reports published after
the 1970s concern the development of catheter devices to ar-
terialize veins, thereby avoiding surgical invasive approaches [21,
22]. In one of these studies [21], the catheter was introduced
from the proximal LAD to the LADV. However, these trials were
not very successful, mainly due to variations in vascular anatomy
and technical problems. In the second study [22], the LADV was
arterialized directly from the left ventricle, but the lack of a valve
resulted in backﬂow into the ventricle and low venous pressure.
Our research aimed to optimize selective cardiac venous ar-
terialization and measure its beneﬁt. Our strategy is quite differ-
ent from those reported in previous studies, as follows:
(i) We used the pig as animal model, instead of dogs and
sheep which were used in former investigations [16, 18]. Pigs
are a more appropriate experimental model because their
arterial and venous cardiac architecture resembles that of
humans and they display a relative lack of natural collateral
circulation [6, 10].
(ii) We have compared our results with a control group of
animals subjected to LAD ligation only. Most previous
studies, however, did not establish these comparisons and
thus could not really evaluate the beneﬁt of cardiac venous
arterialization. Hochberg et al., Møller et al. and Harig et al.
were three of the few groups who performed these compar-
isons [16, 19, 20]. However, the LAD was occluded more
proximally in these studies, which resulted in early death of
all control animals, thus impeding the collection and com-
parison of cardiac data during the following days.
(iii) We have applied several more accurate diagnostic examina-
tions to evaluate the beneﬁts of cardiac venous arterializa-
tion. Thus, unlike previous studies, quantitative analysis of
left ventricular function and precise evaluation of the reduc-
tion in infarct size was made possible [9–16].
(iv) Our team employed up-to-date anaesthetic agents and sur-
gical equipment. Also, as recommended for anastomotic
surgeries, heparin and antiplatelet therapy were adminis-
tered to prevent clotting from interfering with blood ﬂow
through the arterialized cardiac veins.
(v) In the experimental group, the LIMA–LADV anastomosis was
opened immediately after LAD ligation, so the area at risk
was never exposed to ischaemia. The following two main
reasons justiﬁed this procedure. (a) Despite the standardized
timings of ischaemia, the individual LAD distribution creates
variable amounts of necrotic tissue before venous arterializa-
tion is active. Necrotic tissue is irreversibly damaged, and will
not be recovered even if within the area perfused by the
arterialized LADV. It would be impossible to perceive
whether necrosis was due to the induced ischaemia or to in-
efﬁciency of the arterialized LADV. (b) Also, the induced is-
chaemia would increase the number of deaths in the
experimental group. Would they be caused by a wider LAD
arborization, by an abnormally long exposure to ischaemia,
by an extended surgical procedure and/or increased recovery
periods, or simply by the limited revascularization capacity
from the arterialized LADV? All these variables would over-
shadow the real beneﬁt of venous arterialization. In our
study, by not inducing ischaemia, quantiﬁcation of the exact
perfused/non-perfused myocardium by the arterialized
LADV was made clear.
The information provided by our research is limited to the
acute phase of MI, and the animals lacked any atherosclerotic
disease; therefore, further investigations should focus on the
patency of grafts in long-term studies and in atherosclerotic
animal models for translation into the ischaemic disease in
Table 2. Average peak values and area under the curve of cardiac biomarkers in each group
Group cTnI Myoglobin MMB
Peak (ng/ml) AUC Peak (ng/ml) AUC Peak (ng/ml) AUC
Control (mean ± SEM; n = 9) 47 ± 7 2.989 ± 344 703 ± 95 10.441 ± 874 19 ± 5 537 ± 190
Experimental (mean ± SEM; n = 9) 46 ± 8 2.406 ± 194 586 ± 109 9.915 ± 1.788 18 ± 6 472 ± 114
cTnI: concentration of troponin I; MMB: mass assay of creatine kinase.
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humans. Chowdhry et al. have experienced poor results with the
patency of arteriovenous grafts, although all four patients were
free of angina 2 years later [2]. Three reasons might explain this
failure of graft patency, as follows: (i) the saphenous vein was
used as a conduit between the aorta and the middle cardiac
vein, so two anastomoses and a longer circuit were used; (ii) in
each patient, two additional arterial grafts were performed at
major coronary arteries, which could have led to a higher capil-
lary pressure; and (iii) collateral circulation might have developed
during those 2 years.
Analysis of results
In our experimental group, three deaths were caused most prob-
ably by anatomical variations (thin LIMA, bifurcated LADV and
overdeveloped LAD) and one was due to technical problems
(after extubation, the position of the epiglottis was changed
during transportation and delivery to the animal’s quarters,
leading to respiratory arrest and death). Regarding the control
group, three deaths were due to the induced MI, while the
other one seemed to be a result of technical problems (the pig
was not stable enough to be moved to the recovery room).
In the experimental group, there was still a clear ST segment
deﬂection 1 h after surgery, indicating the presence of MI.
Nevertheless, these changes were less pronounced than in the
control group, as revealed by the sum of absolute ST segment
shift (50% lower in the experimental group; P = 0.038), one of
the strongest ECG predictors of mortality [7]. On the fourth day,
complete resolution of these ST deﬂections was recognized in
about half of the pigs in each group. Also, in both groups the
ECGs presented T wave shifts and tachycardia. Although not as
speciﬁc as ST segment deﬂections, these two events are also
common in MI [23].
After surgery, echocardiography in the experimental group
showed that left ventricular wall thicknesses and contractility
remained unchanged. The control group, on the contrary, suf-
fered a clear decline in ejection fraction, with thinning of the
interventricular septum and enlargement of the left ventricular
lumen. In the control group, the tendency for posterior wall
thickening seemed to occur in order to compensate for the dys-
function associated with the interventricular septum.
Peak values and AUCs of all cardiac biomarkers analysed did
not differ between the two groups (P > 0.2). There may be two
reasons for this, as follows: (i) several studies have demonstrated
that reperfusion to ischaemic tissues may exacerbate or acceler-
ate injury, although the mechanisms are still not fully understood
[24]; and (ii) we hypothesize that the impaired venous drainage
(LADV was ligated) might have been another possible cause [23].
A study by Fredericks et al. suggests that troponin I in pigs is a
suitable biomarker for myocardial damage, owing to its cardiac
speciﬁcity [25]. In fact, in their retroperfused group, Harig et al.
reported a troponin I curve that reached its peak at 4 h and then
declined to basal values. They also documented a much lower
troponin I concentration in their retroperfused group compared
with all other groups at 1 h after surgery [20]. We did not
observe any differences between our two groups during the ﬁrst
hour, and peak values were reached at the same times. We
believe this phenomenon requires further investigation. In our
study, because troponin I and MMB are considered to be the
most reliable biomarkers for their cardiac speciﬁcity and
myoglobin can detect MI as early as the ﬁrst 12 h, only the
results for these biomarkers are presented in Table 2.
The percentage of histological lesion in the experimental
group was 50% lower than in the control group (with P < 0.001),
with a large difference (70%) in the amount of necrotic tissue
(5.5 ± 1.0 vs 1.6 ± 0.5%; P < 0.001). There was also nearly 40% less
granulation tissue in the experimental group (8.2 ± 0.5 vs
5.2 ± 0.7%; P = 0.003). In both groups, the lesion was mainly
located at the interventricular septum.
In conclusion, all our cardiac data evidenced a severe MI in the
control group, with high concentrations of cardiac biomarkers,
changes in electrical activity reﬂecting a high value in the sum of
ST segment deviations and a strong impairment in contractility of
the left ventricle, especially from the interventricular septum. A
high percentage of infarcted myocardial lesion (14%) was identi-
ﬁed in those animals. In the experimental group also, MI was iden-
tiﬁed by the rise of cardiac biomarkers, changes in ECGs and by
histological studies, but no dysfunction was revealed by echocardi-
ography on the fourth day. Moreover, the changes detected in
ECGs were of lesser amplitude than those of the control group
and, most importantly, the percentage of histological lesion was
much lower than in the control group. Curiously, cardiac biomar-
kers remained as high as in the control group and did not correl-
ate with the results from the other diagnostic tests. This
phenomenon would require further investigation.
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We read the article by Munz et al. with interest [1]. They aimed to investigate the
beneﬁts of cardiac venous arterialization in reducing acute myocardial infarct size
and its effects on cardiac performance. This study revealed that selective cardiac
venous arterialization can nourish the myocardium and is able to reduce the
infarct size by more than 50%, while protecting cardiac performance. The study is
successfully planned and the results are presented well — thanks to the authors for
their contribution.
In the absence of collateral circulation, coronary occlusion causes myocyte necro-
sis, the extent of which correlates directly with the speed and duration of the oc-
clusion. Early reperfusion of an ischaemia related artery (IRA) would decrease
myocardial necrosis, improve left ventricular (LV) function, and reduce mortality
rates. Opening an occluded IRA, whether early or late, produces survival rates dis-
proportionate to the amount of myocardium salvaged.
A current trial clearly showed that in patients diagnosed with acute coronary syn-
drome, an early invasive approach is superior to a conservative approach [3]. Early
reintervention may limit the extent of myocardial cellular damage compared with
conservative medical strategy in patients with myocardial ischaemia due to early
graft failure as well as in patients with acute myocardial infarction [4]. Myocardial
reperfusion has been shown to improve both short- and long-term survival in
patients who have experienced an AMI. The open artery hypothesis suggests that
survival after AMI depends on improved LV remodeling and healing, electrical sta-
bility, and myocardial perfusion rather than on the reduction of the infarct size
(i.e., myocardial salvage) [5]. Studies showed that late patency of an IRA, as
opposed to persistent occlusion, was independently associated with better 1-year
survival. In a long-term follow-up study of 505 patients who underwent percutan-
eous transluminal coronary angioplasty for post-MI ischaemia, 22 patients with an
open IRA had a lower 5-year mortality rate than patients with a closed IRA. This
held true even for patients with LVEFs <0.50.
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